Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3235]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell...
Dr Laurie Sehn - University of British Columbia, Vancouver, Canada
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )
9 Jan 2012
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma
Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma ( Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group )
9 Jan 2012
Two rituximab dosing strategies for low tumour burden follicular lymphoma...
Prof Brad Kahl - University of Wisconsin, Madison, USA
Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT) ( Prof Brad Kahl - University of Wisconsin, Madison, USA )
9 Jan 2012
Cereblon expression required for anti-myeloma activity of lenalidomide and...
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
9 Jan 2012
The latest for Multiple Myeloma
Prof Paul Richardson - Dana Farber Institute, Boston, USA
The latest for Multiple Myeloma ( Prof Paul Richardson - Dana Farber Institute, Boston, USA )
19 Dec 2011
Myelodysplastic syndrome drug development and combination therapy
Prof Valeria Santini – University of Florence, Italy
Myelodysplastic syndrome drug development and combination therapy ( Prof Valeria Santini – University of Florence, Italy )
19 Dec 2011
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI...
Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765 ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )
19 Dec 2011
Update and new perspectives in the management of MDS
Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA
Update and new perspectives in the management of MDS ( Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA )
19 Dec 2011
New data on aggressive B cell lymphoma
Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA
New data on aggressive B cell lymphoma ( Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA )
19 Dec 2011
Update on the phase III VISTA trial
Dr Jesus San Miguel – University Hospital of Salamanca, Spain
Update on the phase III VISTA trial ( Dr Jesus San Miguel – University Hospital of Salamanca, Spain )
19 Dec 2011
Update on the development of proteasome inhibitors
Dr Philip McCarthy – Roswell Park Cancer Institute, USA
Update on the development of proteasome inhibitors ( Dr Philip McCarthy – Roswell Park Cancer Institute, USA )
19 Dec 2011
Romidepsin treatment in peripheral T cell lymphoma and subsets
Dr Francine Foss – Yale School of Medicine, Connecticut, USA
Romidepsin treatment in peripheral T cell lymphoma and subsets ( Dr Francine Foss – Yale School of Medicine, Connecticut, USA )
19 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation